Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of drugs targeting neurological and cardiovascular conditions. Its structure supports the creation of bioactive molecules due to the presence of both amine and ether functional groups, which enhance binding affinity and solubility. Commonly employed in research settings for designing novel therapeutic agents and in the preparation of chiral building blocks for asymmetric synthesis. Also utilized in the formulation of prodrugs to improve metabolic stability and bioavailability.